Author:
Pectasides D.,Pectasides M.,Farmakis D.,Bountouroglou N.,Nikolaou M.,Koumpou M.,Mylonakis N.,Kosmas C.
Reference46 articles.
1. In vitro cytotoxicity, protein binding, red blood cell partitioning;Pendyala;and biotransformation of oxaliplatin. Cancer Res,1993
2. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute’s Anticancer Drug Screen panel;Rixe;Biochem Pharmacol,1996
3. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy;Misset,1991
4. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer;Levi;Cancer,1992
5. Phase I study of oxaliplatin in patients with advanced cancer;Extra;Cancer Chemother Pharmacol,1990
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献